Association between β-genus human papillomavirus and cutaneous squamous cell carcinoma in immunocompetent individuals-a meta-analysis

JAMA Dermatology

Volumn 152, Issue 12, 2016, Pages 1354-1364

  Chahoud, Jad ^a   Semaan, Adele ^b   Chen, Yong ^b   Cao, Ming ^b   Rieber, Alyssa G ^c   Rady, Peter ^a   Tyring, Stephen K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BETA GENUS HUMAN PAPILLOMAVIRUS; CANCER RISK; DISEASE ASSOCIATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 17; HUMAN PAPILLOMAVIRUS TYPE 20; HUMAN PAPILLOMAVIRUS TYPE 24; HUMAN PAPILLOMAVIRUS TYPE 36; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 8; IMMUNE DEFICIENCY; NONHUMAN; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SKIN CARCINOMA; SYSTEMATIC REVIEW; VIRUS DETECTION; WART VIRUS; ADULT; BETAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; IMMUNOCOMPETENCE; ISOLATION AND PURIFICATION; META ANALYSIS; PAPILLOMAVIRUS INFECTION; SKIN NEOPLASMS; VIROLOGY;

ADULT; BETAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOCOMPETENCE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SKIN NEOPLASMS;

EID: 85011301165     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2015.4530     Document Type: Article

References (50)

1. Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741-760.
2. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-983.
3. Deady S, Sharp L, Comber H. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention. Br J Dermatol. 2014;171(2):324-331.
4. Hollestein LM, de Vries E, Aarts MJ, Schroten C, Nijsten TEC. Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989. J Am Acad Dermatol. 2014; 71(5):896-903.
5. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003; 348(17):1681-1691.
6. Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J. Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol. 2008;43(4):353-360.
7. Aldabagh B, Angeles JGC, Cardones AR, Arron ST. Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg. 2013;39(1 Pt 1):1-23.
8. McLaughlin-Drubin ME. Human papillomaviruses and non-melanoma skin cancer. Semin Oncol. 2015;42(2):284-290.
9. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses(PVs) based on 189 PVtypes and proposaloftaxonomic amendments. Virology. 2010;401(1):70-79.
10. Van Doorslaer K, Tan Q, Xirasagar S, et al. The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 2013;41(Database issue):D571-D578.
11. Feltkamp MCW, Broer R, di Summa FM, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res. 2003;63(10):2695-2700.
12. Lewandowski F, Lutz W. Acase of a not previously described skin disease (Epidemodysplasia verruciformis) [in German]. Arch Derrm Syph. 1922;141:193-203.
13. Reuschenbach M, Tran T, Faulstich F, et al. High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients. Br J Cancer. 2011;104 (8):1334-1341.
14. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin cancer in organ transplant recipients-where dowe stand today? Am J Transplant. 2008;8(11): 2192-2198.
15. Howley PM, Pfister HJ. Beta genus papillomaviruses and skin cancer. Virology. 2015; 479-480:290-296.
16. Leitz J, Reuschenbach M, Lohrey C, et al. Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene. PLoS Pathog. 2014;10(3): e1003957.
17. Viarisio D, Decker KM, Aengeneyndt B, Flechtenmacher C, Gissmann L, Tommasino M. Human papillomavirus type 38 E6 andE7 actas tumour promoters during chemically induced skin carcinogenesis. J Gen Virol. 2013;94(Pt 4):749-752.
18. Wallace NA, Robinson K, Howie HL, Galloway DA. HPV 5and 8E6 abrogate ATR activity resulting in increased persistenceof UVB induced DNA damage. PLoS Pathog. 2012;8(7):e1002807.
19. Buitrago-Pérez Á, Hachimi M, Dueñas M, et al. A humanized mouse model of HPV-associated pathology driven by E7 expression. PLoS One. 2012; 7(7):e41743.
20. Masini C, Fuchs PG, Gabrielli F, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol. 2003;139(7):890-894.
21. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst. 2006;98(6):389-395.
22. Casabonne D, Michael KM, Waterboer T, et al. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nestedin the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2007;121(8):1862-1868.
23. Waterboer T, Abeni D, Sampogna F, et al. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol. 2008;159(2):457-459.
24. Bouwes Bavinck JN, Neale RE, Abeni D, et al; EPI-HPV-UV-CA group. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res. 2010;70(23):9777-9786.
25. Karagas MR, Waterboer T, Li Z, et al; New Hampshire Skin Cancer Study Group. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. BMJ. 2010;341:c2986.
26. Plasmeijer EI, Pandeya N, O'Rourke P, et al. The Association between cutaneous squamous cell carcinoma and betapapillomavirus seropositivity: a cohort study. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1171-1177.
27. Andersson K, Michael KM, Luostarinen T, et al. Prospective study of human papillomavirus seropositivity and risk of nonmelanoma skin cancer. Am J Epidemiol. 2012;175(7):685-695.
28. Struijk L, Hall L, van der Meijden E, et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15(3):529-535.
29. Iannacone MR, Gheit T, Waterboer T, et al. Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2012;21 (8):1303-1313.
30. Struijk L, Bouwes Bavinck JN, Wanningen P, et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol. 2003;121(6):1531-1535.
31. Termorshuizen F, Feltkamp MC, Struijk L, de Gruijl FR, Bavinck JN, van Loveren H. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol. 2004;122(6): 1456-1462.
32. Iannacone MR, Gheit T, Pfister H, et al. Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer. 2014;134(9):2231-2244.
33. Struijk L, van der Meijden E, Kazem S, et al. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosisofprimary human keratinocytes. J Gen Virol. 2008;89(Pt 9):2303-2314.
34. Plasmeijer EI, Neale RE, Buettner PG, et al. Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer. 2010;126(11):2614-2621.
35. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-1101.
37. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455-463.
38. Quint KD, Genders RE, de Koning MN, et al. Human Beta-papillomavirus infection and keratinocyte carcinomas. J Pathol. 2015;235(2): 342-354.
39. Mendoza JA, Jacob Y, Cassonnet P, Favre M. Human papillomavirus type 5E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3. J Virol. 2006;80(24):12420-12424.
40. Shterzer N, Heyman D, Shapiro B, et al. Human papillomavirus types detected in skin warts and cancer differ in their transforming properties but commonly counteract UVB induced protective responses in human keratinocytes. Virology. 2014; 468-470:647-659.
41. White EA, Sowa ME, Tan MJ, et al. Systematic identification of interactions between host cell proteins andE7 oncoproteins from diverse human papillomaviruses. Proc Natl Acad Sci USA. 2012;109 (5):E260-E267.
42. Akgül B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol. 2006;208(2):165-175.
43. Fei JW, de Villiers EM. Differential regulation of cutaneous oncoprotein HPVE6bywtp53, mutant p53R248W and ΔNp63αisHPV type dependent. PLoS One. 2012;7(4):e35540.
44. Cordano P, Gillan V, Bratlie S, et al. The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. Virology. 2008;377(2):408-418.
45. Gabet AS, Accardi R, Bellopede A, et al. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEBJ. 2008;22(2):622-632.
46. Cornet I, Bouvard V, Campo MS, et al. Comparative analysis of transforming properties of E6and E7 from different beta human papillomavirus types. J Virol. 2012;86(4):2366-2370.
47. Cohen DN, Lawson SK, Shaver AC, et al. Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy. Clin Cancer Res. 2015;21(11):2624-2634.
48. Kalinska-Bienias A, Kostrzewa G, Malejczyk M, Ploski R, Majewski S. Possible association between actinic keratosis and the rs7208422 (c.917A→T, p.N306l) polymorphism ofthe EVER2 gene in patients without epidermodysplasia verruciformis. Clin Exp Dermatol. 2015;40(3):318-323.
49. Vuillier F, Gaud G, Guillemot D, Commere P-H, Pons C, Favre M. Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes. PLoS One. 2014;9(2): e89479.
50. Gibbs NK, Norval M. Photoimmunosuppression: a brief overview. Photodermatol Photoimmunol Photomed. 2013;29 (2):57-64.